Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences:
  • The UBS 2016 Global Healthcare Conference on May 24, 2016 at 8:00 a.m. EDT in New York, NY;
  • The Jefferies 2016 Healthcare Conference on June 7, 2016 at 8:30 a.m. EDT in New York, NY; and
  • The JMP Securities Life Sciences Conference on June 22, 2016 at 1:30 p.m. EDT in New York, NY.

A live webcast of Concert's presentations at these conferences may be accessed in the Investors section of the Company's website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Concert's website for 2 weeks following each presentation.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs, advanced clinical candidates or previously studied compounds that have the potential to be improved with deuterium substitution to enhance clinical safety, tolerability and efficacy. The Company is developing a broad pipeline targeting genetic diseases, autoimmune disorders, CNS disorders and inflammatory diseases, among others. For more information, please visit www.concertpharma.com.

Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160517005197/en/

Copyright Business Wire 2010